• Merck limits orders for bladder cancer drug as demand outstrips supply fiercepharma
    March 15, 2019
    When Sanofi said it’d stop making a bladder cancer drug in 2016, one expert predicted there’d be shortages. Fast forward to today, and Merck says it’s done it’s best to ensure global supply, but as the lone manufacturer, it’s having trouble keeping up. 
PharmaSources Customer Service